This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Oncolytic Viruses / Non-viral Gene Therapy Delivery
November 30 - December 1, 2022
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET

Samuel Rabkin
Thomas A Pappas Professor in Neuroscience at Harvard Medical School, USA

Profile

Samuel Rabkin is Professor of Neurosurgery (Microbiology) at Harvard Medical School, Boston MA, and Virologist in Neurosurgery at Massachusetts General Hospital, Boston, MA. He has been involved in the development of oncolytic herpes simplex viruses (oHSVs) for over 25 years, from virus engineering to therapeutic combinations to clinical trial. He obtained his PhD at the University of Chicago, was an Assistant Member at Memorial Sloan-Kettering Cancer Center, New York, NY, and an Associate Professor at Georgetown University Medical Center, Washington DC before moving to Harvard.

Agenda Sessions

  • Advances in the Field of Oncolytic Viruses and Future Outlooks

    8:05am